(Q46684886)
Statements
Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial (English)
Kai M Beeh
Jutta Beier
Michael Meyer
Rainer Zahlten
1 September 2005